Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Yuanqi Biotechnology

Request full access

Intelligent and industrialized cell bank network

ChinaFounded 2015Biotech & Life Sciences

About Yuanqi Biotechnology

Yuanqi Biotechnology, officially known as OriginCell Technology Group, was co-founded in July 2014 by the accomplished entrepreneur Qu Jianguo and the publicly traded company Canature Health (300272). The venture was initiated with a significant first-round investment of 1.5 billion RMB. Qu Jianguo serves as the company's chairman and chief engineer, bringing a wealth of experience from his previous successes. Before delving into the health industry, he founded Shenhua Industrial, one of the first eight companies listed on the Shanghai Stock Exchange, and later established Canature Health, the first publicly-listed home water treatment company in China. This entrepreneurial journey reflects a consistent focus on innovation and market foresight, which he now applies to the life sciences sector.

OriginCell operates within the biotechnology and life sciences markets, focusing on cell technology. The group's core business is the creation of a standardized and intelligent network of cell banks. Its operations are comprehensive, spanning third-party cell storage, the development and manufacturing of automated cryogenic storage equipment for biological samples, immunotherapy drug development, and cell preparation services. The company serves a range of clients, including hospitals and research institutions, providing them with advanced solutions for biological sample cryopreservation. Its business model is diversified across this ecosystem, generating revenue through services and the sale of specialized equipment.

The company's key offerings include automated, intelligent, deep-cryogenic biological sample storage equipment, designed to address the challenges of traditional manual storage. One of its flagship developments is an unmanned 5G-enabled fully automated cell bank. Its subsidiary, Shanghai Origincell Biological Cryo Equipment Co., Ltd., produces a range of products including the BSN Honeycomb-style automated deep-low temperature bio-sample storage equipment (-196°C). These systems aim to ensure sample safety and quality by preventing cross-contamination and avoiding repeated freeze-thaw cycles through patented technologies like a honeycomb storage structure and single-tube picking mechanisms. The company has built a substantial intellectual property portfolio, with hundreds of patents filed and granted domestically and internationally.

Source: Dealroom company data

At a glance

Status
Operational
Employees
17
Open positions
None listed
Dealroom signal
40.1/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Feb 2023 $45M $900M Qatar Investment Authority · Xiamen C&D · RTW Investments · Qiming Venture Partners ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Yuanqi Biotechnology website traffic

Latest recorded traffic for Yuanqi Biotechnology is 130 monthly website visits, down 58.1% over the last three months. Yuanqi Biotechnology's team grew 6.3% over the past year.

Latest monthly visits130 3-month web change-58.1% 1-year team growth+6.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Amygdala NeuroscienceAmygdala's mission is to address the growing unmet need associated with substance use disorder by discovering, developing and commercializing safe and effective pharmacotherapies to treat and prevent addiction Palo Alto, United States Operational 3 $7.6M —
Beckley PsytechClinical-stage biotechnology developing rapid-acting psychedelic medicines Beckley and Stowood, United Kingdom Operational
Nucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine Oxford, United Kingdom Operational
Rosa BiotechAI-driven biosensing and diagnostics company providing outcome-focused biosensing for early disease diagnosis and for use in industrial biotechnology Bristol, United Kingdom Operational
EmpiricoHuge biological datasets, human genetics, and programmable biology to power novel target discovery and development San Diego, United States Operational
BraeburnBraeburn is dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid addiction Washington DC, United States Operational
PredxBioTissue-Based Decision Intelligence for Oncology Bellevue, United States Operational
BiofourmisBiotechnology company that augments personalized care and therapies using digital therapeutics Boston, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Yuanqi Biotechnology in its local ecosystem

Live from Dealroom

The Yuanqi Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

Employees 17 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Yuanqi Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Yuanqi Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.